Blood and tumor study for virus markers in throat cancer
Part of Cancer, Ear, nose & throat, Infections, Mouth & dental clinical trials.
This study looks at virus-related markers and tiny gene regulators (microRNAs) in tumor tissue from people with certain throat cancers caused by human papilloma virus (HPV). It’s observational, meaning it does not change your treatment, but results may help doctors better understand these cancers and how they behave.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have squamous cell cancer in the oropharynx (throat area) or an occult (hidden) tumor with lymph node spread that tested positive for squamous cell cancer.
- Your cancer has been treated with TORS (a type of surgery) and/or radiation (RT), and sometimes chemotherapy (CT).
- At the time of enrollment, cancer should not have spread to distant organs (no distant metastases).
- You can follow study steps, complete questionnaires, and provide written informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for certain markers in people with HPV-related throat cancer that could help doctors choose the best treatment. If you are planning to have surgery for your throat cancer, you may be able to join.
This observational study checks how well a blood test for HPV DNA (and other tumor genetic markers) predicts outcomes in certain throat cancers. It may help doctors better track the disease and plan treatment, because the trial validates these lab signals against real-world results.
This study looks at how tumor DNA found in a blood sample (a “DNA signal”) relates to head and neck cancer in the oropharynx. It may help doctors understand disease status and improve how they monitor treatment, for both HPV-positive and HPV-negative cancers.
This trial studies oropharyngeal (throat) cancer, including certain HPV-related cancers of unknown starting point, using several ways to measure tumor features. The goal is to better understand these cancers and possibly guide future care.
This study looks at certain markers (called p16 and HPV) in tumor samples to better understand oropharynx cancer. It may help doctors learn more about the disease and guide future treatments.
This study checks a blood test that looks for HPV tumor DNA to help doctors decide when to start routine treatment after surgery. It may help some people avoid starting treatment too early or too late based on how the test changes after the operation.
Hear when a new Liquid Biopsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.